// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Clinical and inflammatory characteristics of patients with COPD in primary care: an observational study

Joanne Davies - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Suitability of patients with perceived AECOPD for referral to a COPD unit at a district general hospital

Angela Macfoy - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Dyspnea

N/A

Decline in health status in alpha1 antitrypsin deficiency

Robert Andrew Stockley - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Alpha-1 antitrypsin (A1AT) deficiency

N/A

Modelling peripheral blood eosinophils to identify response to budesonide in COPD: a post-hoc analysis

Mona Bafadhel - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Budesonide

Investigating optimal sputum processing methods for active neutrophil elastase quantification

Charlene Robb - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

Elaszym

Intrauterine growth retardation and lung function in prematurely born young people

Christopher Harris - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Determinants of pulmonary dead space in ventilated newborn infants

Theodore Dassios - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Evolution of tidal volume requirements during the neonatal period in preterm infants supported by pressure limited ventilation

Anne Greenough - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Outcome of infants with right versus left sided congenital diaphragmatic hernia

Anne Greenough - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Congenital diaphragmatic hernia

N/A

Resuscitation of prematurely born infants at birth; is airway obstruction common?

Katie Hunt - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Effect of maturity and infection on the rate of relaxation of the respiratory muscles in ventilated, newborn infants

Theodore Dassios - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Recombinant human (rh)IGF-1/rhIGFBP-3 for prevention of bronchopulmonary dysplasia

Carlo Dani - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Infant Respiratory Distress Syndrome

Mecasermin rinfabate

Shift in very preterm infants with oxyhaemoglobin saturation >94% in room air

Benjamin Stoecklin - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Longitudinal lung function following very premature birth

Christopher Harris - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Spontaneous preterm delivery

N/A

Maternal smoking in pregnancy increases the duration of home oxygen therapy in infants with bronchopulmonary dysplasia

Andrew Prayle - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Infant Respiratory Distress Syndrome

N/A

Mechanical insufflation-exsufflation (MIE): Current UK practice

Emily Ballard - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Ventilation in Motor Neurone Disease (MND): what happens in practice

Emily Ballard - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The use of remote mointoring to assess ventilator adherence and outcome within a regional home mechanical ventilation service

Aashish Vyas - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Facial pressure ulcers amongst children on long term non-invasive ventilation: incidence and management strategies

Elaine Chan - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Acute exposure to intermittent negative airway pressure elicits respiratory long-term facilitation in awake humans

Harry Griffin - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved